Who to call at Aquestive Therapeutics, Inc., and when
Fundz watches for the moments Aquestive Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Aquestive Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aquestive Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aquestive Therapeutics, Inc.. With Fundz connected, it knows.
Aquestive Therapeutics Enters License Agreement with Eton Pharmaceuticals for LIBERVANT®
Contract Type
licensing
Description
On October 13, 2026, Aquestive Therapeutics, Inc. entered into a license agreement granting Eton Pharmaceuticals exclusive U.S. rights to commercialize LIBERVANT® buccal film for seizure clusters in epilepsy patients. The deal includes an upfront fee of $10.0 million and further milestone payments totaling up to $47.5 million
Quick answer
Aquestive Therapeutics Enters License Agreement with Eton Pharmaceuticals for LIBERVANT® (October 14, 2026). Aquestive Therapeutics, Inc. is based in Warren, New Jersey, United States.
- What agreement did Aquestive Therapeutics, Inc. announce on October 14, 2026?
- On October 13, 2026, Aquestive Therapeutics, Inc. entered into a license agreement granting Eton Pharmaceuticals exclusive U.S. rights to commercialize LIBERVANT® buccal film for seizure clusters in epilepsy patients.
- What does Aquestive Therapeutics, Inc. do?
- Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs.
- Where is Aquestive Therapeutics, Inc. based?
- Aquestive Therapeutics, Inc. is based in Warren, New Jersey, United States.
- Which similar companies announced agreements around the same time?
- AbbVie Inc. (November 3, 2026), YD Bio Limited (October 20, 2026), Cognito Therapeutics (October 27, 2026) and Alexion (October 29, 2026) also announced agreements within 45 days of Aquestive Therapeutics, Inc.
Source: Fundz verified event record.
Other recent agreements in Healthcare and Medical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
Related People
Aquestive Therapeutics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.